临床试验/JPRN-UMIN000023414

JPRN-UMIN000023414已完成未知

The study of ANagliptin effects on Glucagon LEvels of type 2 DM patients using insulin / ANGLE study - ANGLE study

Juntendo University0 个研究点目标入组 20 人开始时间: 2017年8月1日最近更新: 2023年10月17日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方: Juntendo University
入组人数: 20

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 20years-old 至 ot applicable（—）
性别: All

入选标准

未提供

排除标准

•1. Type 1 diabetes 2. patients with change of insulin of 4 unit and more within observation period 3. patients with change of kinds of insulin within observation period 4. patients previously treated with anagliptin 5. BMI of 30 and more 6. severe liver disease (AST or ALT 100IU/ L and more) 7. severe kidney disease or serum creatinine of 1.5mg/dl and more 8. severe heart failure or patients with attacks of myocardial infarction and angina 9. patients with stroke within 24 weeks before acquirung consent 10.patients with malignancy 11.severe diabetic complications (neuropathy, retinopathy, nephropathy) 12.severe ketosis including diabetic coma 13.anemia (Hb < 9.5g/dl) 14.enteropathy with abnormal digestion and absorption 15.patients with past history of gastrointestinal resection

研究者

发起方

Juntendo University

相似试验

The study of ANagliptin effects on Glucagon LEvels of type 2 DM patients using insulin / ANGLE study

JPRN-UMIN000024399Juntendo University Hospital20

Effect of anagliptin on plasma glucagon levels determined by LC-MS/MS in patients with type 2 diabetesType 2 diabetes

JPRN-UMIN000028293St. Marianna University School of Medicine24

Effect of glucagon-like-peptide-1 (GLP-1) on left ventricular function during percutaneous coronary intervention (PCI)

ISRCTN77442023Papworth Hospital NHS Foundation Trust (UK)40

进行中（未招募）

Study of the counter-regulation to hypoglycemia during treatment with sitagliptin in subjects with type 2 diabetesType 2 Diabetes Mellitus

EUCTR2014-002685-70-SEund University

进行中（未招募）

Testing Whether Glucagon Solutions Affect the Glucose Levels in the Fat Tissue of Diabetic Patients.

EUCTR2014-002341-22-ATMedizinische Universität Graz; Universitätsklinik für InnereMedizin; Abteilung für Endokrinologie und Stoffwechsel